Temporal Trends and Disparities in Acute Myocardial Infarction Mortality Among Patients with Lipoprotein Metabolism Disorders: A Nationwide CDC-WONDER Analysis (1999–2020).
Vascular Biology · 17.11.2026
DOI: 10.1530/vb-25-0005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular Biology, online erschienen am 17.11.2026. Verfasst von Nazeer Mustafa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dow Medical College, Dow University of Health Sciences , Karachi, Pakistan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lipoprotein metabolism disorders (LMDs) contribute to residual cardiovascular risk following acute myocardial infarction (AMI), yet population-level mortality trends remain poorly defined.
Objective
To evaluate AMI-related mortality trends among U.S. adults with LMDs from 1999–2020.
Methods
A retrospective analysis of CDC WONDER data identified decedents aged ≥25 years with LMDs (ICD-10: E78) contributing to AMI (I21) as underlying cause. Age-adjusted mortality rates (AAMR) per 100,000 were analyzed using joinpoint regression, stratified by demographics.
Results
Among 95,222 deaths, overall AAMR rose from 3.27 (1999) to 4.91 (2020). Three phases emerged: increase (1999–2004; APC: 6.19), stability (2004–2018; APC: -0.39), and resurgence (2018–2020; APC: 6.82). Men had higher AAMR than women (2.88 vs. 1.31). Non-Hispanic Whites (2.1) and Blacks (2.04) showed highest rates; Asians/Pacific Islanders lowest (1.39). Older adults (65–85+ years) bore greatest burden (AAMR: 9.69). Geographically, Midwest (2.33) and West (2.22) exceeded South (1.88) and Northeast (1.77). Non-metropolitan areas had markedly higher AAMR than metropolitan areas (9.08 vs. 2.37). Most deaths occurred in medical facilities (54.65%) versus home (36.71%).
Conclusion
AMI-related mortality among U.S. adults with LMDs increased over two decades, with a concerning resurgence from 2018–2020 coinciding with the COVID-19 pandemic. Persistent disparities by sex, race, age, geography, and urbanization highlight urgent needs for targeted lipid management and equitable healthcare access to reduce cardiovascular mortality in this high-risk population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dow Medical College, Dow University of Health Sciences , Karachi, Pakistan.
- IPM&R, Dow University of Health Sciences , Karachi, Pakistan.
- BS Medical Technology Jinnah Sindh Medical University , Karachi, Pakistan.
ORCID-Profile: Nazeer Mustafa
Zitieren
APA
Mustafa, N., Iqbal, J., Arshad, A., & Mubeen, A. (2026). Temporal Trends and Disparities in Acute Myocardial Infarction Mortality Among Patients with Lipoprotein Metabolism Disorders: A Nationwide CDC-WONDER Analysis (1999–2020). Vascular Biology. https://doi.org/10.1530/vb-25-0005
Vancouver
Mustafa N, Iqbal J, Arshad A, Mubeen A. Temporal Trends and Disparities in Acute Myocardial Infarction Mortality Among Patients with Lipoprotein Metabolism Disorders: A Nationwide CDC-WONDER Analysis (1999–2020). Vascular Biology. 2026. doi:10.1530/vb-25-0005
BibTeX
@article{Mustafa2026,
author = {Mustafa, Nazeer and Iqbal, Javed and Arshad, Amama and Mubeen, Aisha},
title = {Temporal Trends and Disparities in Acute Myocardial Infarction Mortality Among Patients with Lipoprotein Metabolism Disorders: A Nationwide CDC-WONDER Analysis (1999–2020)},
journal = {Vascular Biology},
year = {2026},
doi = {10.1530/vb-25-0005}
}
EUVIMED